31 August 2016
A new report by visiongain estimates that the global immunochemistry market was worth $18.1bn in 2015. These forecasts and others appear in Immunochemistry Reagents, Analysers and Test Kits: World Market 2016-2026: Disease Specific Tests, Rapid Tests, Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anaemia/Vitamin Tests, Infectious Disease Tests, Autoimmune Disease Tests, Tumour Markers, Cardiac Markers, Allergic Blood Tests, Fertility Tests, Thyroid Tests, published in October 2016. Visiongain is a business intelligence company based in London, UK.
The reagents and test kits market is estimated to grow at a CAGR of 7.5% from 2015 to 2020, driven by the rapid tests submarket which is expected to grow at a CAGR of 9.5% from 2015 to 2020.
“The global immunochemistry industry is one of the largest sub- sectors of the global in vitro diagnostics (IVD) market, worth an estimated $18.1bn in 2015. Containing notable submarkets such as disease specific tests, endocrinology test, anaemia/vitamin tests and toxicology testing; this market has benefited from an improvement in both the hardware and software of the industry. Other factors such as the rise of the incidences of cancer, infectious diseases and cardiovascular diseases around the world will continue to fuel demand for better immunochemistry tests in the coming decade; ultimately leading to the emergence of India and China as alternatives to relatively expensive western production. Overall the global immunochemistry industry will progress steadily throughout the forecast period reaching $38.9bn in 2026.”
- Arvind Deol, pharmaceutical market analyst, visiongain, 2016
Visiongain’s new 160-page report provides revenue forecasts to 2026 for the global immunochemistry market, 11 leading submarkets and 9 leading national markets.
It forecasts the size of the immunochemistry market in the US, Japan, EU5: (Germany, France, Italy, Spain, UK), China, India, and the Rest of the World.
Along with revenue prediction for the overall world market, you see forecasts to 2026 for these submarkets:
• Immunochemistry reagents and tests kits
• Immunochemistry analysers
The study also forecasts immunochemistry reagents and tests kits subsectors
• Anaemia/Vitamin tests
• Disease specific tests
• Drugs of abuse/toxicology tests
• Therapeutic drug monitoring
• Endocrinology tests
• Rapid tests
This report profiles these leading companies:
• Siemens Healthcare
• Ortho Clinical Diagnostics
Immunochemistry Reagents, Analysers and Test Kits: World Market 2016-2026: Disease Specific Tests, Rapid Tests, Toxicology Tests, Endocrinology Tests,Therapeutic Drug Monitoring Tests, Anaemia/Vitamin Tests, Infectious Disease Tests, Autoimmune Disease Tests, Tumour Markers, Cardiac Markers, Allergic Blood Tests, Fertility Tests, Thyroid Tests adds to visiongain’s range of analytical reports on industries and markets in healthcare.
The market for ophthalmic drugs is a growing one.
17 June 2019
Visiongain believes the market will see more traditional pharma companies beginning to embrace the generic business in order to take advantage of higher growth rates in this area.
14 June 2019
The market players are increasingly focusing on precision therapies where drug and precision tests are developed simultaneously.
06 June 2019
Market penetration and adoption of new technologies entering the market for antifungal drugs will be crucial for market growth.